Avapritinib Decreased Symptom Burden in Patients With Indolent Systemic Mastocytosis in the Registrational Double-Blind, Placebo-Controlled PIONEER Study
| Title: | Avapritinib Decreased Symptom Burden in Patients With Indolent Systemic Mastocytosis in the Registrational Double-Blind, Placebo-Controlled PIONEER Study |
|---|---|
| Authors: | Giannetti, Matthew, Akin, Cem, Livideanu, Cristina Bulai, Sabato, Vito, Van Daele, Paul, Pongdee, Thanai, Barete, Stéphane, Vadas, Peter, Maurer, Marcus, Siebenhaar, Frank, Triggiani, Massimo, Bonadonna, Patrizia, Hartmann, Karin, Guilarte, Mar, Ogbogu, Princess, Gaudy, Caroline, Bidollari, Ilda, Green, Teresa, Lin, Hui-Min, Roche, Maria, Sullivan, Erin, Castells, Mariana, Elberink, Hanneke Oude |
| Source: | In The Journal of Allergy and Clinical Immunology February 2024 153(2) Supplement:AB254-AB254 |
| Database: | ScienceDirect |
Be the first to leave a comment!